Bristol-Myers Says Its Former Lawyer Can't Testify In IP Battle
By Chris Villani ( August 1, 2022, 12:49 PM EDT) -- Bristol-Myers Squibb Co. told a federal judge that Dana-Farber Cancer Institute should not be allowed to bring in a former BMS patent attorney from McDonnell Boehnen Hulbert & Berghoff LLP to testify against his onetime client as part of an ongoing dispute over immunology patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.